title: Discovering and targeting the epigenetic pathways to treat muscle loss: working toward a paradigm shift in cancer therapeutics.
authors.affiliation: aSchulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota, USA bCentro de Investigacion Medica Aplicada, Universidad de Navarra, Pamplona, Spain cDivision of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Martin E
authors.initials: ME
authors.lastname: Fernandez-Zapico
authors.forename: Maite G
authors.initials: MG
authors.lastname: Fernandez-Barrena
authors.forename: David L
authors.initials: DL
authors.lastname: Marks
authors.forename: Aminah
authors.initials: A
authors.lastname: Jatoi
mesh_terms: D002100:Cachexia / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D044127:Epigenesis, Genetic; D006801:Humans; D018482:Muscle, Skeletal / Q000378:metabolism; D009133:Muscular Atrophy / Q000378:metabolism; D009369:Neoplasms / Q000150:complications*